Debiopharm to Acquire Affinium’s Antibiotic Clinical Assets and Platform

News   Feb 12, 2014

 
Debiopharm to Acquire Affinium’s Antibiotic Clinical Assets and Platform
 
 
 

RELATED ARTICLES

Liquid Biopsy Developed for Multiple Myeloma

News

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past.

READ MORE

A New, Streamlined Approach to Diagnosing and Treating Bowel Cancer

News

Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.

READ MORE

Fermentation Byproduct Suppresses Seizures in Nerve Agent Poisoning

News

A compound found in trace amounts in alcoholic beverages is more effective at combating seizures in rats exposed to an organophosphate nerve agent than the current recommended treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE